Obesity In India

Next-gen pipeline spans higher-dose, combination and oral therapies; company says it can meet India's demand for GLP-1 medicines as the market expands

Updated On: 01 Oct 2026 | 1:34 AM IST

Lifestyle diseases on the rise, shows NFHS-6, though insurance coverage, vaccination rates, maternal care, child health indicators have improved

Updated On: 29 May 2026 | 11:39 PM IST

In a 16-page letter dated April 10 and sent to the Drugs Controller General of India, Lilly said it had halted the campaign 'out of an abundance of regulatory caution' following a March advisory

Updated On: 12 May 2026 | 8:20 AM IST

Global drugmakers are prioritising China and Japan for GLP-1 investments due to stronger pricing power and adoption, while India remains a large but price-sensitive market with slower premium uptake

Updated On: 20 Apr 2026 | 11:26 PM IST

Regulators have been asked to track adverse events as India tightens oversight on popular obesity drugs amid rising demand and concerns over misuse and misleading promotions

Updated On: 04 Apr 2026 | 11:18 AM IST

India is the first major country after Canada where Novo is losing patent on semaglutide and will see an onslaught of generic versions

Updated On: 16 Mar 2026 | 9:25 AM IST

A new global report places India second worldwide for children living with overweight and obesity and warns that rising BMI levels could trigger early hypertension, heart diseases

Updated On: 04 Mar 2026 | 11:50 AM IST

A major Lancet study finds adults with obesity are far more likely to be hospitalised or die from infections, linking nearly one in 10 infection deaths worldwide to excess weight

Updated On: 10 Feb 2026 | 1:51 PM IST

A nationwide LocalCircles survey shows obesity is no longer an individual issue, with most Indians reporting obese family members or friends, underscoring India's growing public health challenge

Updated On: 30 Jan 2026 | 2:48 PM IST

Economic Survey 2025-26 flags rising obesity and ultra-processed food intake as risks to productivity, healthcare spending and public finances, calling for policy action beyond consumer awareness

Updated On: 29 Jan 2026 | 2:24 PM IST

Endocrinologist explains how to build a realistic weight-loss plan that can help you lose fat without regaining it

Updated On: 21 Jan 2026 | 4:33 PM IST

Changing lifestyles, nutritional gaps and untreated mental health issues are pushing chronic diseases into younger age groups across India

Updated On: 12 Jan 2026 | 4:32 PM IST

New research shows people regain weight far faster after stopping obesity drugs than after dieting, with benefits fading quickly and raising questions about how long GLP-1 medicines need to be taken

Updated On: 08 Jan 2026 | 2:39 PM IST

Eating eggs has been repeatedly shown to help people feel fuller for longer and eat less at later meals, including among people who are overweight or obese

Updated On: 08 Jan 2026 | 10:03 AM IST

India still has a critical advantage: ultra-processed foods account for a very small share of current diets

Updated On: 02 Jan 2026 | 9:22 AM IST

Novo's strategy emphasises price cuts and accelerated launches, while Lilly's products benefitted from hitting the market early

Updated On: 24 Dec 2025 | 8:11 AM IST

Why does belly fat creep up after 30 even if nothing has changed? A California-based gastroenterologist trained at AIIMS explains the science behind it and what can help reverse it

Updated On: 23 Dec 2025 | 12:08 PM IST

Entry of generics post March 2026, patient dropouts to affect sales values, say experts

Updated On: 15 Dec 2025 | 12:13 AM IST

From regulating appetite to improving blood sugar control, GLP-1 drugs like Ozempic are emerging as powerful metabolic tools at a time when India urgently needs better solutions

Updated On: 12 Dec 2025 | 4:14 PM IST

Mounjaro is part of a new generation of weight-loss and diabetes drugs that target metabolic hormones. Introduced in March, it was launched ahead of rival Novo Nordisk's Wegovy

Updated On: 07 Nov 2025 | 1:09 PM IST